Industries

• Reset all ×
• Healthcare & Life Sciences ×
• Database ×

Showing 21–30 of 134 results

Sort by popularity Sort by average rating Sort by latest Sort by price: low to high Sort by price: high to low

• 

  Global Molecular Diagnostic Market

  The global molecular diagnostic market is poised to grow by US$ 5,945 million during 2021-2027, progressing at a CAGR of 8.9% during the forecast period, according to data and analytics company StrategyHelix.

  USD 5
• 

  Chemiluminescence Immunoassay (CLIA) Market in China

  A statistic by StrategyHelix indicates that the chemiluminescence immunoassay (CLIA) market in China is expected to increase by US$ 7,883 million from 2021 to 2027, garnering a CAGR of 17.4% during the forecast period.

  USD 15
• 

  Point of Care Testing (POCT) Market in China

  The point of care testing (POCT) market in China was around 1,855 million USD in 2020, reached 2,235 million USD in 2021 (an increase of 20.5% year-on-year), according to StrategyHelix’ analysis.

  USD 15
• 

  Global Point of Care Testing (POCT) Market

  The global point of care testing (POCT) market was around 27 billion USD in 2020, reached 30 billion USD in 2021 (an increase of 9.4% year-on-year), according to StrategyHelix’ analysis.

  USD 15
• 

  In vitro diagnostics (IVD) Market in China

  A statistic by StrategyHelix indicates that the in vitro diagnostics (IVD) market in China is anticipated to expand positively at a CAGR of 15.6% during the forecast period (2021-2027).

  USD 15
• 

  Global In vitro diagnostics (IVD) Market

  A statistic by StrategyHelix indicates that the global in vitro diagnostics (IVD) market is set to grow at a healthy compound annual growth rate (CAGR) of 7% in the next five years.

  USD 20
• 

  Assisted Reproduction Market in China

  The assisted reproduction market in China is set to increase by US$ 9,271 million from 2021 to 2027, representing a compound annual growth rate (CAGR) of 14.2% during the forecast period.

  USD 5
• 

  Drugs for Helicobacter Pylori Infection Market in China

  The drugs for helicobacter pylori infection market in China is set to increase by US$ 5,855 million from 2021 to 2027, representing a compound annual growth rate (CAGR) of 14.2% during the forecast period.

  USD 5
• 

  Inhalation Preparations Market in China

  The inhalation preparations market in China is poised to grow by US$ 3,951 million during 2021-2027, progressing at a CAGR of 12.8% during the forecast period, according to data and analytics company StrategyHelix.

  USD 5
• 

  Drug for Gastrointestinal Diseases Market in China

  According to StrategyHelix, the drug for gastrointestinal diseases market in China is expected to increase by US$ 4,900 million during 2021-2027, expanding at a CAGR of 6.7% during the forecast period.

  USD 5